UBAP1 Human shRNA Plasmid Kit (Locus ID 51271)

Specifications

Product Data
Product Name	UBAP1 Human shRNA Plasmid Kit (Locus ID 51271)
Locus ID	51271
UniProt ID	Q9NZ09
Synonyms	NAG20; SPG80; UAP; UBAP; UBAP-1
Vector	pRS
Format	Retroviral plasmids
Kit Components	UBAP1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 51271). 5µg purified plasmid DNA per construct 29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free.
RefSeq	NM_001171201, NM_001171202, NM_001171203, NM_001171204, NM_016525, NR_033243, NM_016525.2, NM_016525.3, NM_016525.4, NM_001171203.1, NM_001171203.2, NM_001171204.1, NM_001171204.2, NM_001171202.1, NM_001171201.1, BC020950, BC020950.1, BC098141, BC098316, BC099726, BC100668, NM_001171204.3, NM_001171203.3, NM_016525.5
Summary	This gene is a member of the UBA domain family, whose members include proteins having connections to ubiquitin and the ubiquitination pathway. The ubiquitin associated domain is thought to be a non-covalent ubiquitin binding domain consisting of a compact three helix bundle. This particular protein originates from a gene locus in a refined region on chromosome 9 undergoing loss of heterozygosity in nasopharyngeal carcinoma (NPC). Taking into account its cytogenetic location, this UBA domain family member is being studies as a putative target for mutation in nasopharyngeal carcinomas. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
shRNA Design	These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Performance Guaranteed	OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.